Development and validation of an SDA-500 Anopheles stephensi cell line for molecular studies

Verdict. To help address this gap, we established a new embryo-derived Anopheles stephensi cell line. It primarily advances mechanistic understanding rather than explicit pathology endpoints.

What the authors report

Background: Malaria control is increasingly challenged by the urban-adapted vector Anopheles stephensi, yet molecular and cellular tools for this species remain scarce, restricting functional genomic studies and the development of genetic control strategies. Transfection conditions were optimized, with TransIT-PRO showing higher efficiency than Lipofectamine-based reagents.

Key results stated in the abstract include the following. To help address this gap, we established a new embryo-derived Anopheles stephensi cell line. Results: We generated and characterised a novel embryo-derived Anopheles stephensi (SDA-500) cell line capable of sustained growth in vitro. Species identity was confirmed by mitochondrial COI barcoding, and karyotypic analysis revealed a diploid chromosome complement with the presence of a Y chromosome, confirming that at least some cells are of male origin.

Why it matters for mitochondrial biology

Within mitochondrial research, this work maps primarily to mitochondria. The abstract does not lean heavily on pathology language; the contribution appears more mechanistic or systems-level than clinical. Server: biorxiv. Posted 2026-08-15. Synthesis confidence is bounded by abstract completeness.

Study design (abstract-level)

To help address this gap, we established a new embryo-derived Anopheles stephensi cell line. Results: We generated and characterised a novel embryo-derived Anopheles stephensi (SDA-500) cell line capable of sustained growth in vitro. Using a dual-luciferase reporter assay, of several promoters tested the Anopheles gambiae polyubiquitin promoter exhibited the strongest and most consistent transcriptional activity in SDA-500 cells.

Principal findings

1. To help address this gap, we established a new embryo-derived Anopheles stephensi cell line.
2. Results: We generated and characterised a novel embryo-derived Anopheles stephensi (SDA-500) cell line capable of sustained growth in vitro.
3. Species identity was confirmed by mitochondrial COI barcoding, and karyotypic analysis revealed a diploid chromosome complement with the presence of a Y chromosome, confirming that at least some cells are of male origin.
4. This resource provides a useful system for functional genomics and molecular manipulation in Anopheles stephensi and is expected to facilitate studies of mosquito biology and contribute to the development of novel malaria control strategies.

Limitations of this brief

• This Mitos brief is an abstract-level synthesis of a preprint; it is not peer review and not a substitute for reading the full paper.
• Preprint status: findings may change with revision or journal review.
• Effect sizes, n numbers, statistics, and full experimental controls are typically incomplete at abstract resolution.
• Evidence appears non-human or in vitro from the abstract; translational claims require independent scrutiny.
• Primary source: biorxiv DOI 10.64898/2026.08.14.744812 (posted 2026-08-15).

Open scientific questions

• Which specific experimental panels in the full paper establish the strongest causal claim, and how robust are the controls?
• How do these findings sit relative to prior literature on the same pathway—replication, contradiction, or incremental extension?

Bottom line

For mitochondrial biologists focused on mitochondria, this preprint is worth full-text review if the topic matches your program. Abstract-level takeaway: To help address this gap, we established a new embryo-derived Anopheles stephensi cell line. Confirm methods, effect sizes, and controls in the full PDF before citing the result as established.

Bibliographic record

Abstract-based editorial synthesis by Mitos. Not peer review.